Comabella M - Search Results

1

Body fluid biomarkers in multiple sclerosis.

Comabella M, Montalban X. Comabella M, et al. Lancet Neurol. 2014 Jan;13(1):113-26. doi: 10.1016/S1474-4422(13)70233-3. Lancet Neurol. 2014. PMID: 24331797 Review.

2

Bromocriptine and postpartum cerebral angiopathy: a causal relationship?

Comabella M, Alvarez-Sabin J, Rovira A, Codina A. Comabella M, et al. Neurology. 1996 Jun;46(6):1754-6. doi: 10.1212/wnl.46.6.1754. Neurology. 1996. PMID: 8649587

3

Late-onset metachromatic leukodystrophy clinically presenting as isolated peripheral neuropathy: compound heterozygosity for the IVS2+1G-->A mutation and a newly identified missense mutation (Thr408Ile) in a Spanish family.

Comabella M, Waye JS, Raguer N, Eng B, Domínguez C, Navarro C, Borrás C, Krivit W, Montalbán X. Comabella M, et al. Ann Neurol. 2001 Jul;50(1):108-12. Ann Neurol. 2001. PMID: 11456299

4

Assessment of different treatment failure criteria in a cohort of relapsing-remitting multiple sclerosis patients treated with interferon beta: implications for clinical trials.

Río J, Nos C, Tintoré M, Borrás C, Galán I, Comabella M, Montalban X. Río J, et al. Among authors: comabella m. Ann Neurol. 2002 Oct;52(4):400-6. doi: 10.1002/ana.10290. Ann Neurol. 2002. PMID: 12325067 Clinical Trial.

5

New diagnostic criteria for multiple sclerosis: application in first demyelinating episode.

Tintoré M, Rovira A, Río J, Nos C, Grivé E, Sastre-Garriga J, Pericot I, Sánchez E, Comabella M, Montalban X. Tintoré M, et al. Among authors: comabella m. Neurology. 2003 Jan 14;60(1):27-30. doi: 10.1212/wnl.60.1.27. Neurology. 2003. PMID: 12525713

6

Conversion to multiple sclerosis after a clinically isolated syndrome of the brainstem: cranial magnetic resonance imaging, cerebrospinal fluid and neurophysiological findings.

Sastre-Garriga J, Tintoré M, Rovira A, Grivé E, Pericot I, Comabella M, Thompson AJ, Montalban X. Sastre-Garriga J, et al. Among authors: comabella m. Mult Scler. 2003 Feb;9(1):39-43. doi: 10.1191/1352458503ms847oa. Mult Scler. 2003. PMID: 12617267 Clinical Trial.

7

A genomic screen of Spanish multiple sclerosis patients reveals multiple loci associated with the disease.

Goertsches R, Villoslada P, Comabella M, Montalban X, Navarro A, de la Concha EG, Arroyo R, Lopez de Munain A, Otaegui D, Palacios R, Perez-Tur J, Jonasdottir A, Benediktsson K, Fossdal R, Sawcer S, Setakis E, Compston A; Spanish MS Genetics Group. Goertsches R, et al. Among authors: comabella m. J Neuroimmunol. 2003 Oct;143(1-2):124-8. doi: 10.1016/j.jneuroim.2003.08.026. J Neuroimmunol. 2003. PMID: 14575929

8

Decreased MMP-9 production in primary progressive multiple sclerosis patients.

Sastre-Garriga J, Comabella M, Brieva L, Rovira A, Tintoré M, Montalban X. Sastre-Garriga J, et al. Among authors: comabella m. Mult Scler. 2004 Aug;10(4):376-80. doi: 10.1191/1352458504ms1058oa. Mult Scler. 2004. PMID: 15327032

9

Genetic analysis of SLC11A1 polymorphisms in multiple sclerosis patients.

Comabella M, Altet L, Peris F, Villoslada P, Sánchez A, Montalban X. Comabella M, et al. Mult Scler. 2004 Dec;10(6):618-20. doi: 10.1191/1352458504ms1097oa. Mult Scler. 2004. PMID: 15584484

10

Plasma osteopontin levels in multiple sclerosis.

Comabella M, Pericot I, Goertsches R, Nos C, Castillo M, Blas Navarro J, Río J, Montalban X. Comabella M, et al. J Neuroimmunol. 2005 Jan;158(1-2):231-9. doi: 10.1016/j.jneuroim.2004.09.004. J Neuroimmunol. 2005. PMID: 15589058 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results